NCT07412496

A Study to Evaluate the Use of Topical Ocular BL1332 for the Management of Postoperative Ocular Pain Following Photorefractive Keratectomy

A Randomized, Vehicle-Controlled, Double-Masked, Parallel-Group Study to Evaluate the Use of Topical Ocular BL1332 for the Management of Postoperative Ocular Pain Following Photorefractive Keratectomy

• Status: Not Yet Recruiting
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 123 (estimated)
• Sponsor: Bausch & Lomb Incorporated · Industry
• Sex: All
• Age: 18 Years – 58 Years
• Healthy volunteers: Not accepted

Summary

This is a multicenter, double-masked study to evaluate the use of Topical Ocular BL1332 for the management of post-operative pain after Photorefractive Keratectomy (PRK) surgery.

Conditions

• Pain, Postoperative

Interventions

Type	Name	Description
DRUG	Topical Ocular BL1332 low dose	Administered 5 times a day
DRUG	Topical Ocular BL1332 high dose	Administered 5 times a day
DRUG	BL1332 Vehicle ophthalmic vehicle	Administered 5 times a day

Timeline

• Start date: 2026-04-01
• Primary completion: 2027-02-01
• Completion: 2027-02-01
• First posted: 2026-02-17
• Last updated: 2026-02-17

Regulatory

• FDA-regulated drug study